Cargando…
Carbonic anhydrase inhibitors in patients with respiratory failure and metabolic alkalosis: a systematic review and meta-analysis of randomized controlled trials
BACKGROUND: Metabolic alkalosis is common in patients with respiratory failure and may delay weaning in mechanically ventilated patients. Carbonic anhydrase inhibitors block renal bicarbonate reabsorption, and thus reverse metabolic alkalosis. The objective of this systematic review is to assess the...
Autores principales: | Tanios, Bassem Y, Omran, Maryam O, Noujeim, Carlos, Lotfi, Tamara, Mallat, Samir S, Bou-Khalil, Pierre K, Akl, Elie A, Itani, Houssam S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205780/ https://www.ncbi.nlm.nih.gov/pubmed/30371345 http://dx.doi.org/10.1186/s13054-018-2207-6 |
Ejemplares similares
-
Free versus Fixed Combination Antihypertensive Therapy for Essential Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Mallat, Samir G., et al.
Publicado: (2016) -
Current perspectives on combination therapy in the management of hypertension
por: Mallat, Samir G, et al.
Publicado: (2013) -
Trial sequential analysis suggested the potential overestimated effect of carbonic anhydrase inhibitor for respiratory failure and metabolic alkalosis
por: Luo, Meng-Si, et al.
Publicado: (2019) -
Rituximab use in adult primary glomerulopathy: where is the evidence?
por: Mallat, Samir G, et al.
Publicado: (2016) -
METABOLIC ALKALOSIS DRIVING RESPIRATORY FAILURE IN POST ACUTECOVID-19 SYNDROME
por: HEILBRONN, JACKSON, et al.
Publicado: (2021)